Synthesis and Bovine β 3 -Adrenergic Agonistic Activities of a Novel Series of Aryloxypropanolamines.-23 Compounds of type (III), (VIII), (XVI), and (XX) are prepared and tested for their β 3 -adrenergic agonistic activities. (III) shows the best ratio between potency and affinity against β 3 -adrenoceptors. -(EL HADRI, A.; NICOLLE, E.; GUILLAUME, M. C.; LECLERC, G.; PIETRI-ROUXEL, F.; STROSBERG, A. D.; ARCHIMBAULT, PH.; Pharmazie 56 (2001) 7, 517-522; Dep. Pharmacochim. Mol./Glucides, CNRS, Univ. Joseph Fourier, F-38243 Meylan, Fr.; EN)
Ketone derivatives
Ketone derivatives Q 0370New Series of N-Substituted Phenyl Ketone Oxime Ethers: Synthesis and Bovine β 3 -Adrenergic Agonistic Activities. -Title ethers (V) are prepared via the intermediate epoxides as the key compounds. The crude epoxides are employed without purification for the subsequent reactions with alkyl, arylalkyl and aryl amines like (IV). The bovine β 3 -adrenoceptor and adenylyl cyclase activation properties of the ethers are evaluated. Benzodioxole dicarboxylate derivative (Ve) shows the highest agonistic affinity and potency as well as the highest intrinsic activity. The antagonists (Va), (Vb), and (Vd) are of interest as a tool for further conclusive functional identification of β 3 -adrenoceptors. Ketone oxime ethers are considered as an alternative to the arylethanolamine or aryloxypropanol amine structure in the search for specific β 3 -adrenergic ligands. -(EL HADRI, A.; NICOLLE*, E.; LECLERC, G.; PIETRI-ROUXEL, F.; STROSBERG, A. D.; ARCHIMBAULT, P.; Pharmazie 58 (2003) 1, 13-17; Lab. Chim. Org., Groupe Pharmacochim. Mol., Fac. Pharm., Univ. Joseph Fourier, F-38240 Meylan, Fr.; Eng.) -H. Hoennerscheid 20-097
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.